1
|
Sydó N, Iftikhar U, Csulak E, Meza A, Merkely B, Bonikowske AR, Carta KAG, Hussain N, Assaf Y, Murphy JG, Lopez-Jimenez F, Squires RW, Bailey KR, Allison TG. Exercise Test Predicts Both Noncardiovascular and Cardiovascular Death in a Primary Prevention Population. Mayo Clin Proc 2023; 98:1297-1309. [PMID: 37661140 DOI: 10.1016/j.mayocp.2023.05.029] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/26/2023] [Revised: 04/30/2023] [Accepted: 05/30/2023] [Indexed: 09/05/2023]
Abstract
OBJECTIVE To identify specific causes of death and determine the prevalence of noncardiovascular (non-CV) deaths in an exercise test referral population while testing whether exercise test parameters predict non-CV as well as CV deaths. PATIENTS AND METHODS Non-imaging exercise tests on patients 30 to 79 years of age from September 1993 to December 2010 were reviewed. Patients with baseline CV diseases and non-Minnesota residents were excluded. Mortality through January 2016 was obtained through Mayo Clinic Records and the Minnesota Death Index. Exercise test abnormalities included low functional aerobic capacity (ie, less than 80%), heart rate recovery (ie, less than 13 beats/min), low chronotropic index (ie, less than 0.8), and abnormal exercise electrocardiogram (ECG) of greater than or equal to 1.0 mm ST depression or elevation. We also combined these four abnormalities into a composite exercise test score (EX_SCORE). Statistical analyses consisted of Cox regression adjusted for age, sex, diabetes, hypertension, obesity, current and past smoking, and heart rate-lowering drug. RESULTS The study identified 13,382 patients (females: n=4736, 35.4%, 50.5±10.5 years of age). During 12.7±5.0 years of follow-up, there were 849 deaths (6.3%); of these 162 (19.1%) were from CV; 687 (80.9%) were non-CV. Hazard ratios for non-CV death were significant for low functional aerobic capacity (HR, 1.42; 95% CI, 1.19 to 1.69; P<.0001), abnormal heart rate recovery (HR, 1.36; 95% CI, 1.15 to 1.61; P<.0033), and low chronotropic index (HR, 1.49; 95% CI, 1.26 to 1.77; P<.0001), whereas abnormal exercise ECG was not significant. All exercise test abnormalities including EX_SCORE were more strongly associated with CV death versus non-CV death except abnormal exercise ECG. CONCLUSION Non-CV deaths predominated in this primary prevention cohort. Exercise test abnormalities not only predicted CV death but also non-CV death.
Collapse
Affiliation(s)
- Nóra Sydó
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
| | - Umair Iftikhar
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA
| | - Emese Csulak
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Alejandra Meza
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA
| | - Béla Merkely
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | | | | | - Nasir Hussain
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA
| | - Yazan Assaf
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA
| | - Joseph G Murphy
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA
| | | | - Ray W Squires
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA
| | - Kent R Bailey
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA
| | - Thomas G Allison
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA; Department of Pediatric and Adolescent Medicine, Division of Preventive Cardiology, Mayo Clinic, Rochester, MN, USA
| |
Collapse
|
2
|
Nikbakht HA, Rezaianzadeh A, Seif M, Shojaie L, Ghoddusi Johari M, Ghaem H. Physical activity and metabolic syndrome: A population base study (forest and tree model algorithms). Clin Nutr ESPEN 2023; 56:173-179. [PMID: 37344069 DOI: 10.1016/j.clnesp.2023.05.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Revised: 04/28/2023] [Accepted: 05/20/2023] [Indexed: 06/23/2023]
Abstract
BACKGROUND & AIM Lifestyle changes, prominently low mobility in recent years, have increased the prevalence of metabolic syndrome (MetS), and cardiovascular disease risk. This study aimed to determine the relationship between physical activity and MetS using modern statistical methods in a population-based study. METHODS The target population included 10,663 people aged 40-70 years in phase 1 of the Persian Kharameh cohort study conducted in 2017. The data used in this study had questions about physical activity, demographic, anthropometrics, blood pressure, and biochemical data. RESULTS Participants who their activity was within the fourth quarter were 36% less likely to develop MetS than the participants in the first quarter. In the decision-Tree algorithm with all variables, physical activity was significant after gender and comorbidity. With a lack of comorbidities and physical activity less than 2338 Metabolic Equivalent of Task (MET) and age greater than 53 years, the probability was 26.7% for the male population. For the female population, if associated with comorbidities, a history of diabetes in first-degree relatives, or both, the chance of developing MetS was estimated to be 70.4%. In the decision-tree algorithm, 56.0% of the predictions for MetS were due to gender. After gender, the presence of comorbidities, age, occupation, family history of diabetes, place of residence, and physical activity was discovered as the essential variables in predicting and identifying factors associated with MetS, respectively. CONCLUSION Modern statistical methods can be used in similar research due to better presentation of results in applied clinical laws. An essential approach for treating the syndrome and preventing its complications is a lifestyle change, including educating about physical activity and promoting it.
Collapse
Affiliation(s)
- Hossein-Ali Nikbakht
- Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
| | - Abbas Rezaianzadeh
- Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mozhgan Seif
- Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Layla Shojaie
- Division of GI/Liver, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
| | | | - Haleh Ghaem
- Non-Communicable Diseases Research Center, Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
| |
Collapse
|
3
|
Lonardo A. The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers. Expert Rev Clin Pharmacol 2023; 16:891-911. [PMID: 37722710 DOI: 10.1080/17512433.2023.2259306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2023] [Accepted: 09/12/2023] [Indexed: 09/20/2023]
Abstract
INTRODUCTION Metabolic syndrome (MetS), i.e. the cluster of cardiometabolic risk factors comprising visceral obesity, impaired glucose metabolism, arterial hypertension and atherogenic dyslipidemia, is prevalent globally and exacts a heavy toll on health care expenditures. AREAS COVERED The pathophenotypes of individual traits of the MetS in adults are discussed first, with strong emphasis on nonalcoholic fatty liver disease (NAFLD) and sex differences. Next, I discuss recent studies on phenotypic and outcome heterogeneity of the MetS, highlighting the role of NAFLD, sex, reproductive status, and depressive disorders. In the second half of the article, the therapeutic implications of the variable MetS types and features are analyzed, focusing on the most recent developments, and guidelines. EXPERT OPINION I have identified physiological, pathological, social and medical sources of phenotypical heterogeneity in the MetS and its constitutive traits. Improved understanding of these variables may be utilized in the setting of future precision medicine approaches in the field of metabolic disorders and target organ damage.
Collapse
Affiliation(s)
- Amedeo Lonardo
- Operating Unit of Metabolic Syndrome, Azienda Ospedaliero-Unversitaria di Modena, Ospedale Civile di Baggiovara, Baggiovara, Modena, Italy
| |
Collapse
|
4
|
Gallardo-Alfaro L, Bibiloni MDM, Bouzas C, Mascaró CM, Martínez-González MÁ, Salas-Salvadó J, Corella D, Schröder H, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, Lopez-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem L, Bueno-Cavanillas A, Micó RM, Pintó X, Gaforio JJ, Ortíz-Ramos M, Altés-Boronat A, Luca BL, Daimiel L, Ros E, Sayon-Orea C, Becerra-Tomás N, Gimenez-Alba IM, Castañer O, Abete I, Tojal-Sierra L, Pérez-López J, Torres-Collado L, Colom A, Garcia-Rios A, Castro-Barquero S, Bernal R, Santos-Lozano JM, Fernandez-Lazaro CI, Hernández-Alonso P, Saiz C, Zomeño MD, Zulet MA, Belló-Mora MC, Basterra-Gortari FJ, Canudas S, Goday A, Tur JA. Physical activity and metabolic syndrome severity among older adults at cardiovascular risk: 1-Year trends. Nutr Metab Cardiovasc Dis 2021; 31:2870-2886. [PMID: 34366176 DOI: 10.1016/j.numecd.2021.06.015] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Revised: 06/08/2021] [Accepted: 06/21/2021] [Indexed: 12/26/2022]
Abstract
BACKGROUND AND AIMS Modifiable lifestyle factors, such as physical activity (PA) and Mediterranean diet (MD), decrease metabolic syndrome (MetS). The aim was to assess 1-year changes of leisure-time physical activity (LTPA), sedentary behavior, and diet quality according to MetS severity in older population at high cardiovascular risk. METHODS AND RESULTS Prospective analysis of 55-75-year-old 4359 overweight/obese participants with MetS (PREDIMED-Plus trial) categorized in tertiles according to 1-year changes of a validated MetS severity score (MetSSS). Anthropometrics, visceral adiposity index, triglycerides and glucose index, dietary nutrient intake, biochemical marker levels, dietary inflammatory index, and depression symptoms were measured. Diet quality was assessed by 17-item MD questionnaire. PAs were self-reported using the Minnesota-REGICOR Short Physical Activity Questionnaire and 30-s chair stand test. Sedentary behaviors were measured using the Spanish version of the Nurses' Health Study questionnaire. After 1-year follow-up, decreasing MetSSS was associated with an anti-inflammatory dietary pattern, high intake of vegetables, fruits, legumes, nuts, whole grain cereals, white fish, and bluefish and low intake of refined cereals, red and processed meat, cookies/sweets, and snacks/ready-to-eat-meals. It resulted in high intake of polyunsaturated fatty acids, omega-3 fatty acids, protein, fiber, vitamins B1, B6, B9, C, D, potassium, magnesium, and phosphorus and low glycemic index and saturated fatty acid, trans fatty acid, and carbohydrates intake. Regarding PA and sedentary behavior, decreasing MetSSS was associated with increased moderate-to-vigorous LTPA, chair stand test, and decreased sedentary and TV-viewing time. CONCLUSION Decreasing MetSSS was associated with an anti-inflammatory dietary pattern, high LTPA, high MD adherence, low sedentary time, and low depression risk.
Collapse
Affiliation(s)
- Laura Gallardo-Alfaro
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain; Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Maria Del Mar Bibiloni
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain; Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Cristina Bouzas
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain; Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Catalina M Mascaró
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain; Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Miguel Ángel Martínez-González
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; University of Navarra, Department of Preventive Medicine and Public Health, IDISNA, 31008 Pamplona, Spain; Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, USA
| | - Jordi Salas-Salvadó
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Human Nutrition Unit, Biochemistry and Biotechnology Department, IISPV, Hospital Universitari de Sant Joan. Universitat Rovira I Virgili, 43201 Reus, Spain
| | - Dolores Corella
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Department of Preventive Medicine, University of Valencia, 46100 Valencia, Spain
| | - Helmut Schröder
- Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), 08003 Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain
| | - J Alfredo Martínez
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Cardiometabolics Nutrition Program, IMDEA Food, CEI UAM + CSIC, 28049 Madrid, Spain; Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, 31008 Pamplona, Spain
| | - Ángel M Alonso-Gómez
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, 48013 Vitoria-Gasteiz, Spain
| | - Julia Wärnberg
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, 29071 Málaga, Spain
| | - Jesús Vioque
- CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Miguel Hernández University, Instituto de Investigación Sanitaria y Biomédica de Alicante, ISABIAL-UMH, 46020 Alicante, Spain
| | - Dora Romaguera
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - José Lopez-Miranda
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, 14004 Córdoba, Spain
| | - Ramon Estruch
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain
| | - Francisco J Tinahones
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Virgen de la Victoria Hospital, Department of Endocrinology, University of Málaga, 29010 Málaga, Spain
| | - José Lapetra
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, 41013 Sevilla, Spain
| | - Luís Serra-Majem
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Institute for Biomedical Research, University of Las Palmas de Gran Canaria, 35016 Las Palmas, Spain
| | - Aurora Bueno-Cavanillas
- CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Department of Preventive Medicine, University of Granada, 18071 Granada, Spain
| | - Rafael M Micó
- CIBER Diabetes y enfermedades metabólicas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Institute of Biomedicine (IBIOMED), University of León, 24071 Leon, Spain
| | - Xavier Pintó
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - José J Gaforio
- CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Department of Health Sciences, Center for Advanced Studies in Olive Grove and Olive Oils, University of Jaen, 23071 Jaen, Spain
| | - María Ortíz-Ramos
- Department of Endocrinology and Nutrition, Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain
| | - Andreu Altés-Boronat
- Department of Endocrinology, IDIBAPS, Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain
| | - Bogdana L Luca
- Department of Endocrinology, Fundación Jiménez-Díaz, 28040 Madrid, Spain
| | - Lidia Daimiel
- Nutritional Control of the Epigenome Group, Precision Nutrition and Obesity Program.IMDEA Food, CEI UAM + CSIC, 28049 Madrid, Spain
| | - Emilio Ros
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Lipid Clinic, Department of Endocrinology and Nutrition, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain
| | - Carmen Sayon-Orea
- University of Navarra, Department of Preventive Medicine and Public Health, IDISNA, 31008 Pamplona, Spain; Servicio Navarro de Salud, Osasunbidea, 31003, Pamplona, Spain
| | - Nerea Becerra-Tomás
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Human Nutrition Unit, Biochemistry and Biotechnology Department, IISPV, Hospital Universitari de Sant Joan. Universitat Rovira I Virgili, 43201 Reus, Spain
| | - Ignacio Manuel Gimenez-Alba
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Department of Preventive Medicine, University of Valencia, 46100 Valencia, Spain
| | - Olga Castañer
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), 08003 Barcelona, Spain
| | - Itziar Abete
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, 31008 Pamplona, Spain
| | - Lucas Tojal-Sierra
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, 48013 Vitoria-Gasteiz, Spain
| | - Jéssica Pérez-López
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, 29071 Málaga, Spain
| | - Laura Torres-Collado
- Miguel Hernández University, Instituto de Investigación Sanitaria y Biomédica de Alicante, ISABIAL-UMH, 46020 Alicante, Spain
| | - Antoni Colom
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Antonio Garcia-Rios
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, 14004 Córdoba, Spain
| | - Sara Castro-Barquero
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain
| | - Rosa Bernal
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Virgen de la Victoria Hospital, Department of Endocrinology, University of Málaga, 29010 Málaga, Spain
| | - José Manuel Santos-Lozano
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, 41013 Sevilla, Spain
| | - Cesar I Fernandez-Lazaro
- University of Navarra, Department of Preventive Medicine and Public Health, IDISNA, 31008 Pamplona, Spain
| | - Pablo Hernández-Alonso
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Human Nutrition Unit, Biochemistry and Biotechnology Department, IISPV, Hospital Universitari de Sant Joan. Universitat Rovira I Virgili, 43201 Reus, Spain
| | - Carmen Saiz
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Department of Preventive Medicine, University of Valencia, 46100 Valencia, Spain
| | - Maria Dolors Zomeño
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), 08003 Barcelona, Spain
| | - Maria Angeles Zulet
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, 31008 Pamplona, Spain
| | - Maria C Belló-Mora
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, 48013 Vitoria-Gasteiz, Spain
| | - F Javier Basterra-Gortari
- University of Navarra, Department of Preventive Medicine and Public Health, IDISNA, 31008 Pamplona, Spain; Servicio Navarro de Salud, Osasunbidea, 31003, Pamplona, Spain
| | - Silvia Canudas
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Human Nutrition Unit, Biochemistry and Biotechnology Department, IISPV, Hospital Universitari de Sant Joan. Universitat Rovira I Virgili, 43201 Reus, Spain
| | - Albert Goday
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d'Investigació Mèdica (IMIM), 08003 Barcelona, Spain
| | - Josep A Tur
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain; Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain.
| |
Collapse
|
5
|
Quarta S, Massaro M, Chervenkov M, Ivanova T, Dimitrova D, Jorge R, Andrade V, Philippou E, Zisimou C, Maksimova V, Smilkov K, Ackova DG, Miloseva L, Ruskovska T, Deligiannidou GE, Kontogiorgis CA, Sánchez-Meca J, Pinto P, García-Conesa MT. Persistent Moderate-to-Weak Mediterranean Diet Adherence and Low Scoring for Plant-Based Foods across Several Southern European Countries: Are We Overlooking the Mediterranean Diet Recommendations? Nutrients 2021; 13:nu13051432. [PMID: 33922771 PMCID: PMC8145023 DOI: 10.3390/nu13051432] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2021] [Revised: 04/19/2021] [Accepted: 04/21/2021] [Indexed: 01/15/2023] Open
Abstract
The Mediterranean diet (MD) has been sponsored worldwide as a healthy and sustainable diet. Our aim was to update and compare MD adherence and food choices across several Southern European countries: Spain (SP), Portugal (PT), Italy (IT), Greece (GR), and Cyprus (CY) (MED, Mediterranean), and Bulgaria (BG) and the Republic of North Macedonia (NMK) (non-MED, non-Mediterranean). Participants (N = 3145, ≥18 y) completed a survey (MeDiWeB) with sociodemographic, anthropometric, and food questions (14-item Mediterranean Diet Adherence Screener, 14-MEDAS). The MED and non-MED populations showed moderate (7.08 ± 1.96) and weak (5.58 ± 1.82) MD adherence, respectively, with significant yet small differences across countries (SP > PT > GR > IT > CY > BG > NMK, p-value < 0.001). The MED participants scored higher than the non-MED ones for most of the Mediterranean-typical foods, with the greatest differences found for olive oil (OO) and white meat preference. In most countries, ≥70% of the participants reported quantities of red meat, butter, sweet drinks, and desserts below the recommended cutoff points, whereas <50% achieved the targets for plant-based foods, OO, fish, and wine. Being a woman and increasing age were associated with superior adherence (p-value < 0.001), but differences were rather small. Our results suggest that the campaigns carried out to support and reinforce the MD and to promote plant-based foods have limited success across Southern Europe, and that more hard-hitting strategies are needed.
Collapse
Affiliation(s)
- Stefano Quarta
- Laboratory of Biochemistry and Molecular Biology, Department of Biological and Environmental Sciences and Technologies, University of Salento, 73100 Lecce, Italy;
| | - Marika Massaro
- National Research Council (CNR), Institute of Clinical Physiology, 73100 Lecce, Italy;
| | - Mihail Chervenkov
- Faculty of Veterinary Medicine, University of Forestry, 1797 Sofia, Bulgaria;
- Slow Food in Bulgaria, 9 Pierre De Geytre St. bl. 3, 1113 Sofia, Bulgaria; (T.I.); (D.D.)
| | - Teodora Ivanova
- Slow Food in Bulgaria, 9 Pierre De Geytre St. bl. 3, 1113 Sofia, Bulgaria; (T.I.); (D.D.)
- Department of Plant and Fungal Diversity and Resources, Institute of Biodiversity and Ecosystem Research, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria
| | - Dessislava Dimitrova
- Slow Food in Bulgaria, 9 Pierre De Geytre St. bl. 3, 1113 Sofia, Bulgaria; (T.I.); (D.D.)
- Department of Plant and Fungal Diversity and Resources, Institute of Biodiversity and Ecosystem Research, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria
| | - Rui Jorge
- Instituto Politécnico de Santarém, Escola Superior Agraria, 2001-904 Santarém, Portugal; (R.J.); (V.A.)
- Life Quality Research Centre (CIEQV), IPSantarém/IPLeiria, 2040-413 Rio Maior, Portugal
- Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz, 2829-511 Monte de Caparica, Portugal
| | - Vanda Andrade
- Instituto Politécnico de Santarém, Escola Superior Agraria, 2001-904 Santarém, Portugal; (R.J.); (V.A.)
| | - Elena Philippou
- Department of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, Nicosia 1700, Cyprus; (E.P.); (C.Z.)
- Department of Nutritional Sciences, King’s College London, London SE1 9NH, UK
| | - Constantinos Zisimou
- Department of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, Nicosia 1700, Cyprus; (E.P.); (C.Z.)
| | - Viktorija Maksimova
- Faculty of Medical Sciences, University Goce Delcev, str. Krste Misirkov, No. 10-A, POB 201, 2000 Stip, North Macedonia; (V.M.); (K.S.); (D.G.A.); (L.M.); (T.R.)
| | - Katarina Smilkov
- Faculty of Medical Sciences, University Goce Delcev, str. Krste Misirkov, No. 10-A, POB 201, 2000 Stip, North Macedonia; (V.M.); (K.S.); (D.G.A.); (L.M.); (T.R.)
| | - Darinka Gjorgieva Ackova
- Faculty of Medical Sciences, University Goce Delcev, str. Krste Misirkov, No. 10-A, POB 201, 2000 Stip, North Macedonia; (V.M.); (K.S.); (D.G.A.); (L.M.); (T.R.)
| | - Lence Miloseva
- Faculty of Medical Sciences, University Goce Delcev, str. Krste Misirkov, No. 10-A, POB 201, 2000 Stip, North Macedonia; (V.M.); (K.S.); (D.G.A.); (L.M.); (T.R.)
| | - Tatjana Ruskovska
- Faculty of Medical Sciences, University Goce Delcev, str. Krste Misirkov, No. 10-A, POB 201, 2000 Stip, North Macedonia; (V.M.); (K.S.); (D.G.A.); (L.M.); (T.R.)
| | - Georgia Eirini Deligiannidou
- Laboratory of Hygiene and Environmental Protection, School of Medicine, Democritus University of Thrace, Dragana, 68100 Alexandroupolis, Greece; (G.E.D.); (C.A.K.)
| | - Christos A. Kontogiorgis
- Laboratory of Hygiene and Environmental Protection, School of Medicine, Democritus University of Thrace, Dragana, 68100 Alexandroupolis, Greece; (G.E.D.); (C.A.K.)
| | - Julio Sánchez-Meca
- Department of Basic Psychology & Methodology, Faculty of Psychology, University of Murcia, 30100 Murcia, Spain;
| | - Paula Pinto
- Instituto Politécnico de Santarém, Escola Superior Agraria, 2001-904 Santarém, Portugal; (R.J.); (V.A.)
- Life Quality Research Centre (CIEQV), IPSantarém/IPLeiria, 2040-413 Rio Maior, Portugal
- Correspondence: (P.P.); (M-T.G.-C.); Tel.: +34-(968)396-276 (M-T.G.-C.)
| | - María-Teresa García-Conesa
- Research Group on Quality, Safety and Bioactivity of Plant Foods, Centro de Edafología y Biología Aplicada del Segura-Consejo Superior de Investigaciones Científicas (CEBAS-CSIC), Campus de Espinardo, P.O. Box 164, 30100 Murcia, Spain
- Correspondence: (P.P.); (M-T.G.-C.); Tel.: +34-(968)396-276 (M-T.G.-C.)
| |
Collapse
|
6
|
Ducharme-Smith K, Chambers R, Garcia-Larsen V, Larzelere F, Kenney A, Reid R, Nelson L, Richards J, Begay M, Barlow A, Rosenstock S. Native Youth Participating in the Together on Diabetes 12-Month Home-Visiting Program Reported Improvements in Alternative Healthy Eating Index-2010 Diet Quality Domains Likely to Be Associated With Blood Pressure and Glycemic Control. J Acad Nutr Diet 2021; 121:1125-1135. [PMID: 33547030 DOI: 10.1016/j.jand.2020.12.017] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2020] [Revised: 12/08/2020] [Accepted: 12/18/2020] [Indexed: 10/22/2022]
Abstract
BACKGROUND The Together on Diabetes (TOD) intervention was a home-visiting diabetes prevention and management program for Native youth. OBJECTIVES (1) Examine the impact of the TOD program on diet quality using the Alternative Healthy Eating Index (AHEI-2010); (2) determine association between diet quality and cardiometabolic health. DESIGN The TOD program was conducted from October 2012 to June 2014 and was evaluated using a pretest-posttest study design from baseline to 12 months. Dietary intake was assessed using a food frequency questionnaire. PARTICIPANTS/SETTING There were 240 participants between 10 and 19 years of age from 4 reservation-based, rural tribal communities in the southwestern United States that had been diagnosed with T2DM or prediabetes or were identified as at risk based on body mass index and a qualifying laboratory test. INTERVENTION Youth were taught a 12-lesson curriculum on goal setting, nutrition, and life skills education. MAIN OUTCOME MEASURES Behavioral and physiologic outcomes related to diabetes. STATISTICAL ANALYSIS Changes in AHEI-2010 score and associations with cardiometabolic measures were tested, over time, using adjusted longitudinal linear mixed-effects models. RESULTS The study sample reported an average energy intake of 2016 kcal/d (±1260) and AHEI-2010 score of 47.4 (±7.4) (range: 0-110, higher = better diet quality), indicating low diet quality at baseline. At 12 months' follow-up, there was a reduction in kilocalories (mean = -346 kcal/d; P < .001), sugar-sweetened beverages (mean = -2 fluid oz/d; P = .032), red/processed meat (mean = -1.5 oz/d; P = .008), and sodium (mean = -650 mg/d; P < .001) but no change in AHEI-2010 score (P = .600). The change in systolic blood pressure from baseline to 12 months for participants within the highest AHEI-2010 quartile group was significantly larger than the change in participants within the lowest quartile group (mean = -5.90 mm Hg; P = .036). CONCLUSIONS Despite stable AHEI-2010 scores during follow-up, there were improvements in diet quality domains likely to be associated with cardiometabolic health. Home-visiting programs like TOD are promising interventions for decreasing dietary intake of poor-quality foods.
Collapse
|
7
|
Sasaki N, Watanabe K, Kawakami N. Personal values in adolescence and their associations with metabolic biomarkers in adulthood: a Japanese population-based study. Biopsychosoc Med 2020; 14:26. [PMID: 33042217 PMCID: PMC7542755 DOI: 10.1186/s13030-020-00197-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/17/2020] [Accepted: 09/30/2020] [Indexed: 12/25/2022] Open
Abstract
Background Personal values, which are formed in early life, can have an impact on health outcome later in life. Objective The aim of this study is to investigate the relation between personal values in adolescence and bio-indicators related to metabolic syndrome (MetS) in adulthood. Participants and Methods The longitudinal data used was from the Japanese Study on Stratification, Health, Income, and Neighborhood (J-SHINE). Personal values in adolescence were retrospectively obtained in 2017 from a self-reporting questionnaire, composed of value priorities and commitment to the values. Venous samples were collected in 2012 for low and high-density lipoprotein (LDL, HDL) cholesterol and hemoglobin A1c (HbA1c). Body mass index (BMI), waist circumference and systolic and diastolic blood pressure (SBP, DBP) were also measured. The associations of each variable were examined by partial correlation analysis. In addition, multiple linear regression analysis was conducted to examine overall associations between personal values and the sum of standardized scores (Z-score) of the biomarkers as a proxy of MetS. Results The total population (n = 668) included 261 men and 407 women. For men, the personal value priority of “Having influence on society” was associated with high HDL cholesterol (0.133, p = 0.032) and “Cherishing familiar people” with low waist circumference (r = -0.129, p = 0.049), low SBP, and high DBP (r = -0.135, p = 0.039; r = 0.134, p = 0.041). For women, “Not bothering others” was associated with high SBP and low DBP (r = 0.125, p = 0.015; r = -0.123, p = 0.017). "Economically succeeding" was associated with a worse outcome (β = 0.162, p = 0.042) in men. Conclusions Although some significant associations were found between personal values in adolescence and MetS-related markers in adulthood, the overall associations were not strong. Culturally prevailing values were likely to be associated with a good outcome of metabolic health.
Collapse
Affiliation(s)
- Natsu Sasaki
- Department of Mental Health, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan
| | - Kazuhiro Watanabe
- Department of Mental Health, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan
| | - Norito Kawakami
- Department of Mental Health, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan
| |
Collapse
|
8
|
Nikbakht HA, Rezaianzadeh A, Seif M, Ghaem H. Prevalence of metabolic syndrome and its components among a population-based study in south of Iran, PERSIAN Kharameh cohort study. CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH 2020. [DOI: 10.1016/j.cegh.2020.01.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
|
9
|
Gallardo-Alfaro L, Bibiloni MDM, Mascaró CM, Montemayor S, Ruiz-Canela M, Salas-Salvadó J, Corella D, Fitó M, Romaguera D, Vioque J, Alonso-Gómez ÁM, Wärnberg J, Martínez JA, Serra-Majem L, Estruch R, Fernández-García JC, Lapetra J, Pintó X, García Ríos A, Bueno-Cavanillas A, Gaforio JJ, Matía-Martín P, Daimiel L, Micó-Pérez RM, Vidal J, Vázquez C, Ros E, Fernandez-Lázaro CI, Becerra-Tomás N, Gimenez-Alba IM, Zomeño MD, Konieczna J, Compañ-Gabucio L, Tojal-Sierra L, Pérez-López J, Zulet MÁ, Casañas-Quintana T, Castro-Barquero S, Gómez-Pérez AM, Santos-Lozano JM, Galera A, Basterra-Gortari FJ, Basora J, Saiz C, Pérez-Vega KA, Galmés-Panadés AM, Tercero-Maciá C, Sorto-Sánchez C, Sayón-Orea C, García-Gavilán J, Muñoz-Martínez J, Tur JA. Leisure-Time Physical Activity, Sedentary Behaviour and Diet Quality are Associated with Metabolic Syndrome Severity: The PREDIMED-Plus Study. Nutrients 2020; 12:nu12041013. [PMID: 32272653 PMCID: PMC7230557 DOI: 10.3390/nu12041013] [Citation(s) in RCA: 43] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2020] [Revised: 03/31/2020] [Accepted: 04/01/2020] [Indexed: 12/13/2022] Open
Abstract
Healthy lifestyle factors, such as physical activity (PA) and Mediterranean diet (MD), decrease the likelihood of developing metabolic syndrome (MetS). The aim of this study was to report main lifestyle components and related factors according to the MetS severity. Cross-sectional analysis was done of baseline lifestyle factors from 5739 participants with overweight/obesity and MetS features (aged 55–75 years) included in the PREDIMED-PLUS primary cardiovascular prevention randomized trial. Participants were categorized in tertiles according to a validated MetS severity score (MetSSS). Anthropometrics, visceral adiposity index, dietary nutrient intake, biochemical marker levels, as well as a Dietary Inflammatory Index and depression symptoms (Beck Depression Inventory-II) were measured. Diet quality was assessed using a 17-item energy-restricted MD questionnaire. Duration and intensity of PA was self-reported using the Minnesota-REGICOR Short Physical Activity Questionnaire. Sedentary behaviours were measured using the Spanish version of the Nurses’ Health Study questionnaire. The 30 s chair stand test was also assessed. Participants with highest MetSSS showed higher values of cardiovascular risk factors (except for total cholesterol and LDL cholesterol), depression risk, sedentary and TV viewing time, and lower moderate and vigorous leisure-time physical activity (LTPA). Highest MetSSS participants tended to a pro-inflammatory dietary pattern and tended to lower MD adherence. In addition, they showed lower carbohydrate and nut intake and higher intake of protein, saturated and trans fatty acids, cholesterol, iodine, sodium, red and processed meat products, other oils different from olive oil and spirit alcoholic drinks. The highest MetS severity score was associated with lower moderate and vigorous LTPA and higher sedentary time and depression risk, as they tended to a pro-inflammatory dietary pattern and lower MD adherence.
Collapse
Affiliation(s)
- Laura Gallardo-Alfaro
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Maria del Mar Bibiloni
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Catalina M. Mascaró
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Sofía Montemayor
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Miguel Ruiz-Canela
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Preventive Medicine and Public Health, IdISNA, University of Navarra, 31008 Pamplona, Spain
| | - Jordi Salas-Salvadó
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Human Nutrition Unit, Biochemistry and Biotechnology Department, IISPV, Universitat Rovira i Virgili, 43201 Reus, Spain
| | - Dolores Corella
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Preventive Medicine, University of Valencia, 46100 Valencia, Spain
| | - Montserrat Fitó
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d’Investigació Mèdica (IMIM), 08003 Barcelona, Spain
| | - Dora Romaguera
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Jesús Vioque
- Nutritional Epidemiology Unit, Miguel Hernández University, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), 46020 Alicante, Spain; (J.V.); (L.C.-G.)
- CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (A.B.-C.); (J.J.G.)
| | - Ángel M. Alonso-Gómez
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, 48013 Vitoria-Gasteiz, Spain
| | - Julia Wärnberg
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, 29071 Málaga, Spain
| | - J. Alfredo Martínez
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Precision Nutrition Program, IMDEA Food, CEI UAM + CSIC, 28049 Madrid, Spain
- Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, 31008 Pamplona, Spain
| | - Lluís Serra-Majem
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Institute for Biomedical Research, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain
| | - Ramon Estruch
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain
| | - José Carlos Fernández-García
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Virgen de la Victoria Hospital, Department of Endocrinology, University of Málaga, 29010 Málaga, Spain
| | - José Lapetra
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, 41013 Sevilla, Spain
| | - Xavier Pintó
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - Antonio García Ríos
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, 14004 Cordoba, Spain
| | - Aurora Bueno-Cavanillas
- CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (A.B.-C.); (J.J.G.)
- Department of Preventive Medicine, University of Granada, 18071 Granada, Spain
| | - José J. Gaforio
- CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (A.B.-C.); (J.J.G.)
- Department of Health Sciences, Centro de Estudios Avanzados en Olivar y Aceites de Oliva, University of Jaen, 23071 Jaen, Spain
| | - Pilar Matía-Martín
- Department of Endocrinology and Nutrition, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain;
| | - Lidia Daimiel
- Nutritional Genomics and Epigenomics Group, IMDEA Food, CEI UAM + CSIC, 28049 Madrid, Spain;
| | - Rafael M. Micó-Pérez
- CIBER Diabetes y Enfermedades Metabólicas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain;
- Network of Researchers REDI Fundación SEMERGEN, 28009 Madrid, Spain
| | - Josep Vidal
- Department of Endocrinology, IDIBAPS, Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain;
| | - Clotilde Vázquez
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Endocrinology, Fundación Jiménez-Díaz, 28040 Madrid, Spain
| | - Emilio Ros
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Lipid Clinic, Department of Endocrinology and Nutrition, Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain
| | - Cesar Ignacio Fernandez-Lázaro
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Preventive Medicine and Public Health, IdISNA, University of Navarra, 31008 Pamplona, Spain
| | - Nerea Becerra-Tomás
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Human Nutrition Unit, Biochemistry and Biotechnology Department, IISPV, Universitat Rovira i Virgili, 43201 Reus, Spain
| | - Ignacio Manuel Gimenez-Alba
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Preventive Medicine, University of Valencia, 46100 Valencia, Spain
| | - María Dolors Zomeño
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d’Investigació Mèdica (IMIM), 08003 Barcelona, Spain
| | - Jadwiga Konieczna
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | - Laura Compañ-Gabucio
- Nutritional Epidemiology Unit, Miguel Hernández University, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), 46020 Alicante, Spain; (J.V.); (L.C.-G.)
- CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (A.B.-C.); (J.J.G.)
| | - Lucas Tojal-Sierra
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, 48013 Vitoria-Gasteiz, Spain
| | - Jéssica Pérez-López
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, 29071 Málaga, Spain
| | - M. Ángeles Zulet
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Precision Nutrition Program, IMDEA Food, CEI UAM + CSIC, 28049 Madrid, Spain
| | - Tamara Casañas-Quintana
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Institute for Biomedical Research, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain
| | - Sara Castro-Barquero
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Medicine, Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain
| | - Ana María Gómez-Pérez
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Virgen de la Victoria Hospital, Department of Endocrinology, University of Málaga, 29010 Málaga, Spain
| | - José Manuel Santos-Lozano
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, 41013 Sevilla, Spain
| | - Ana Galera
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, 08907 Barcelona, Spain
| | - F. Javier Basterra-Gortari
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Preventive Medicine and Public Health, IdISNA, University of Navarra, 31008 Pamplona, Spain
- Servicio Navarro de Salud, Osasunbidea. 31071 Pamplona, Spain
| | - Josep Basora
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Human Nutrition Unit, Biochemistry and Biotechnology Department, IISPV, Universitat Rovira i Virgili, 43201 Reus, Spain
| | - Carmen Saiz
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Preventive Medicine, University of Valencia, 46100 Valencia, Spain
| | - Karla Alejandra Pérez-Vega
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d’Investigació Mèdica (IMIM), 08003 Barcelona, Spain
| | - Aina M. Galmés-Panadés
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
| | | | - Carolina Sorto-Sánchez
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, 48013 Vitoria-Gasteiz, Spain
| | - Carmen Sayón-Orea
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Department of Preventive Medicine and Public Health, IdISNA, University of Navarra, 31008 Pamplona, Spain
- Servicio Navarro de Salud, Osasunbidea. 31071 Pamplona, Spain
| | - Jesús García-Gavilán
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Human Nutrition Unit, Biochemistry and Biotechnology Department, IISPV, Universitat Rovira i Virgili, 43201 Reus, Spain
| | - Júlia Muñoz-Martínez
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Nutritional Epidemiology Unit, Miguel Hernández University, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), 46020 Alicante, Spain; (J.V.); (L.C.-G.)
| | - Josep A. Tur
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain; (L.G.-A.); (M.d.M.B.); (C.M.M.); (S.M.); (M.R.-C.); (J.S.-S.); (D.C.); (M.F.); (D.R.); (Á.M.A.-G.); (J.W.); (J.A.M.); (L.S.-M.); (R.E.); (J.C.F.-G.); (J.L.); (X.P.); (A.G.R.); (C.V.); (E.R.); (C.I.F.-L.); (N.B.-T.); (I.M.G.-A.); (M.D.Z.); (J.K.); (L.T.-S.); (J.P.-L.); (M.Á.Z.); (T.C.-Q.); (S.C.-B.); (A.M.G.-P.); (J.M.S.-L.); (A.G.); (F.J.B.-G.); (J.B.); (C.S.); (K.A.P.-V.); (A.M.G.-P.); (C.S.-S.); (C.S.-O.); (J.G.-G.); (J.M.-M.)
- Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, 07122 Palma de Mallorca, Spain
- Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
- Correspondence: ; Tel.: +34-971-1731; Fax: +34-971-173184
| |
Collapse
|
10
|
Evaluation of the physical activity level, nutrition quality, and depression in patients with metabolic syndrome: Comparative study: Erratum. Medicine (Baltimore) 2018; 97:e10886. [PMID: 29794797 PMCID: PMC6392559 DOI: 10.1097/md.0000000000010886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|